For example, aging (the main risk factor for AD) is associated with low serum levels of IGF-1 (Piriz et al., 2011), and type 2 diabetes is associated with peripheral hyperinsulinemia and low brain insulin levels that could result in reduced Aβ clearance (Giuffrida et al., 2012). This evidence concerns the gene INS and Alzheimer disease.